Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Return on Assets (2016 - 2025)

Historic Return on Assets for CytomX Therapeutics (CTMX) over the last 11 years, with Q3 2025 value amounting to 0.17%.

  • CytomX Therapeutics' Return on Assets rose 800.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.2% for FY2024, which is 2000.0% up from last year.
  • CytomX Therapeutics' Return on Assets amounted to 0.17% in Q3 2025, which was up 800.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, CytomX Therapeutics' Return on Assets ranged from a high of 0.38% in Q1 2025 and a low of 0.52% during Q3 2022
  • For the 5-year period, CytomX Therapeutics' Return on Assets averaged around 0.1%, with its median value being 0.19% (2023).
  • Per our database at Business Quant, CytomX Therapeutics' Return on Assets tumbled by -2400bps in 2022 and then skyrocketed by 4700bps in 2023.
  • CytomX Therapeutics' Return on Assets (Quarter) stood at 0.33% in 2021, then decreased by -25bps to 0.41% in 2022, then skyrocketed by 99bps to 0.0% in 2023, then soared by 9228bps to 0.25% in 2024, then crashed by -32bps to 0.17% in 2025.
  • Its Return on Assets stands at 0.17% for Q3 2025, versus 0.35% for Q2 2025 and 0.38% for Q1 2025.